Truesdale Matthew D, Mues Adam C, Sartori Samantha, Casazza Cristin N, Hruby Gregory W, Harik Lara R, O'Toole Kathleen M, Badani Ketan K, Pérez-Lanzac Alberto, Landman Jaime
Department of Urology, University of California, San Francisco, CA, USA.
JSLS. 2011 Oct-Dec;15(4):509-16. doi: 10.4293/108680811X13176785204157.
Cryoablation is an acceptable treatment option for small renal cortical neoplasms (RCN). Unlike extirpative interventions, intraoperative needle biopsy is the only pathologic data for ablated tumors. It is imperative that sampled tissue accurately captures pathology. We studied the optimal intraoperative needle core biopsy protocol for small RCN during laparoscopic renal cryoablation (LCA).
Patients with RCN<4cm underwent intraoperative biopsy during LCA. Four biopsy cores were taken per tumor, 2 before and 2 after LCA by using both a standard and modified technique. Standard technique: needle biopsy device was deployed after insertion into the renal tissue at a depth of 5mm. Modified technique: needle biopsy device was deployed 1mm outside of the renal tissue. Biopsies were examined and compared with reference standard pathology. Percentage agreement was calculated across biopsy types (standard vs. modified) and time points (pre- vs. postcryoablation). Logistic regression was used to identify factors impacting biopsy accuracy.
Thirty patients with 33 RCNs underwent LCA. The mean patient age was 69.1±8.0yrs, and mean tumor size was 2.3±0.7cm. No significant bleeding resulted from biopsies. A definitive diagnosis was made in 31/33 RCNs (94.0%). Ten tumors (30.3%) were benign, 21 (63.7%) were malignant, and 2 (6.0%) were nondiagnostic. Biopsy length was significantly longer using the standard vs. modified technique with mean lengths of 9.3mm vs. 7.0mm, respectively (P=.02). Highest agreement was seen in preablation biopsies (90.3%). A significant association with agreement was seen for younger age (P=.05) and larger tumor size (P=.02).
Younger age and larger tumor size were associated with improved accuracy. Preoperative sampling resulted in superior accuracy and the standard technique resulted in significantly longer cores. Use of preablation standard biopsy technique may result in the most accurate pathologic diagnosis for patients undergoing cryoablation for small RCNs.
冷冻消融是治疗小肾皮质肿瘤(RCN)的一种可接受的治疗选择。与切除性干预不同,术中针吸活检是消融肿瘤的唯一病理数据。至关重要的是,所取组织要准确反映病理情况。我们研究了腹腔镜肾冷冻消融(LCA)期间小RCN的最佳术中针芯活检方案。
RCN<4cm的患者在LCA期间接受术中活检。每个肿瘤取4条活检组织芯,LCA前取2条,LCA后取2条,采用标准技术和改良技术。标准技术:针吸活检装置在插入肾组织5mm深度后展开。改良技术:针吸活检装置在肾组织外1mm处展开。对活检组织进行检查并与参考标准病理进行比较。计算不同活检类型(标准与改良)和时间点(冷冻消融前与后)的一致性百分比。采用逻辑回归确定影响活检准确性的因素。
30例患者的33个RCN接受了LCA。患者平均年龄为69.1±8.0岁,平均肿瘤大小为2.3±0.7cm。活检未导致明显出血。33个RCN中有31个(94.0%)做出了明确诊断。10个肿瘤(30.3%)为良性,21个(63.7%)为恶性,2个(6.0%)未明确诊断。采用标准技术时活检组织芯长度明显长于改良技术,平均长度分别为9.3mm和7.0mm(P = 0.02)。冷冻消融前活检的一致性最高(90.3%)。年龄较小(P = 0.05)和肿瘤较大(P = 0.02)与一致性显著相关。
年龄较小和肿瘤较大与更高的准确性相关。术前取样准确性更高,标准技术导致活检组织芯明显更长。对于接受小RCN冷冻消融的患者,采用冷冻消融前标准活检技术可能会获得最准确的病理诊断。